PubMed · 1994 · 16 citations · 0 references
MedicineCardiologyNuclear MedicineCardiac Nuclear MedicineDiagnostic ImagingNuclear CardiologyCardiac ImagingCardiac Nuclear ImagingCardiovascular ImagingMyocardial Perfusion ImagingPositron Emission TomographyCardiac Pet ImagingMyocardial Extraction FractionMyocardial Perfusion ScintigraphyMyocardial Perfusion TracersMyocardial Tracer Uptake AssessmentMyocardial Uptake QuantificationPositron Emission Tomography Myocardial ImagingTracer Quantification
The present study describes extraction fraction and uptake measurements of the [11C]methyl triphenyl phosphonium (11C-MTP), a promising positron emission tomography (PET) agent for cardiac imaging. PET imaging was performed in mongrel dogs. Under physiological flow conditions 11C-MTP uptake reached a maximum within the first 10 minutes after injection and remained constant during the entire observation period of 80 minutes. Over the same time period, the heart/blood ratio was 46-106:1, and the heart/lung ratio 14:1. Following permanent occlusion of the left anterior descending coronary artery, 11C-MTP uptake in the normally perfused myocardium also reached a maximum at 10 minutes after injection, whereas in the infarcted area there was no significant accumulation of 11C-MTP. For a time period of 80 minutes the noninfarcted/infarcted myocardium ratio was 12:1. Extraction was measured in anesthetized dogs with a double isotope method using 99mTc-HSA as the reference tracer. The extraction fraction was 91% at a flow of 69 mL/min/100g. As flow increased to five-fold (342 mL/min/100g) following administration of adenosine, extraction fell to 61%. Following coronary artery occlusion, the 11C-MTP content in the myocardium was highly correlated (r = 0.93, p < 0.01; y = 10.46 + 0.92x) with the microsphere determined regional myocardial blood flow.